MCRB
Seres Therapeutics (MCRB)
$05
About Seres Therapeutics (MCRB)
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Details
Daily high
$7.40
Daily low
$6.72
Price at open
$6.72
52 Week High
$29.98
52 Week Low
$5.31
Market cap
63.9M
Dividend yield
0.00%
Volume
73,901
Avg. volume
89,442
P/E ratio
-1.32
Seres Therapeutics News
Details
Daily high
$7.40
Daily low
$6.72
Price at open
$6.72
52 Week High
$29.98
52 Week Low
$5.31
Market cap
63.9M
Dividend yield
0.00%
Volume
73,901
Avg. volume
89,442
P/E ratio
-1.32